FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/02/062325 [Registered on: 06/02/2024] Trial Registered Prospectively
Last Modified On: 03/02/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Comparison of Enhanced Recovery After Surgery (ERAS) protocol with conventional care in patient’s understanding Modified Radical Mastectomy for Carcinoma breast  
Scientific Title of Study   Comparison of Enhanced Recovery After Surgery (ERAS) protocol with Conventional Care in patients undergoing Modified Radical Mastectomy for carcinoma breast- a Randomized Controlled Trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr.Shivanand Hosamani 
Designation  Junior Resident  
Affiliation  Jawaharlal Institute of Postgraduate Medical Education and Research 
Address  Jawaharlal Institute of Postgraduate Medical Education and Research JIPMER Campus Rd, Gorimedu, Dhanvantari Nagar, Puducherry, 605006.

Pondicherry
PONDICHERRY
605006
India 
Phone  9591565080  
Fax    
Email  shosamani87@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr. Balamourougan K 
Designation  Additional professor 
Affiliation  Jawaharlal Institute of Postgraduate Medical Education and Research 
Address  Jawaharlal Institute of Postgraduate Medical Education and Research JIPMER Campus Rd, Gorimedu, Dhanvantari Nagar, Puducherry, 605006.

Pondicherry
PONDICHERRY
605006
India 
Phone  9443617089  
Fax    
Email  drbalak@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR Balamourougan K 
Designation  Additional professor  
Affiliation  Jawaharlal Institute of Postgraduate Medical Education and Research 
Address  Jawaharlal Institute of Postgraduate Medical Education and Research JIPMER Campus Rd, Gorimedu, Dhanvantari Nagar, Puducherry, 605006.

Pondicherry
PONDICHERRY
605006
India 
Phone  9443617089  
Fax    
Email  drbalak@gmail.com  
 
Source of Monetary or Material Support  
Jawaharlal Institute of Postgraduate Medical Education and Research 
 
Primary Sponsor  
Name  Jawaharlal Institute of Postgraduate Medical Education and Research JIPMER  
Address  Jawaharlal Institute of Postgraduate Medical Education and Research JIPMER Campus Rd, Gorimedu, Dhanvantari Nagar, 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR SHIVANAND   jipmer   Jawaharlal Institute of Postgraduate Medical Education and Research JIPMER Campus Rd, Gorimedu, Dhanvantari Nagar, Puducherry, 605006.
Pondicherry
PONDICHERRY 
9591565080

shosamani87@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE INTERVENTIONL STUDIES  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C509||Malignant neoplasm of breast of unspecified site,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  -To study the effect of ERAS protocol on patient undergoing modified radical mastectomy  In the ERAS group, the management protocol includes the following. During the pre-operative period, counseling will be given by investigators on the day before surgery regarding multimodal pain control methods and peri-operative expectations. Clear fluids up to 2 hours before surgery. Preoperative carbohydrate loading 100 gm of dextrose in 400ml of water the night before surgery and 50mg in 200ml of water 2 hours before surgery. Preoperative Paracetamol 1 gram + 75 mg of Pregabalin 2 hours before surgery Injection Ondansetron 8 Mg 2 hrs before surgery Preoperative prophylactic antibiotics, Injection Augmentin 1.2 gms half an hour before incision. Intra operative euvolemic will be maintained by crystalloids at 2 ml/ kg. normothermia will be maintained Intra operative minimal use of sevoflurane ( end tidal sevo 1.5%), oxygen in air Preoperative Pecs 1 and Pecs 2 block after induction of anesthesia before incision percutaneous or intraoperative Pectoral block, given at the end of surgery Injection Dexamethasone 8mg at the beginning+Injection Ondansetron 4mg at the end of surgery 15 mg of intravenous ketorolac during closure of incision Early cessation of intravenous fluid. Orals(clear fluids) will be started 2 hours after surgery or on demand by patient, and if tolerated will be escalated to solid diet. IV fluids will be stopped once orals is tolerated. Early ambulation on the same evening with assistance. Patient will be encouraged to do 4-8 walks daily from POD 1. Injection Paracetamol 1gm/IV 8TH hourly for the first 48 hours and injection Tramadol 50 mg IV SOS will be given postoperatively. If post-operative pain by VAS score 4 Inj. Morphine /tramadol / fentanyl will be given as rescue analgesics.  
Comparator Agent  Conventional Care in patients undergoing Modified Radical Mastectomy for carcinoma breast  in control group Overnight fasting from 10 PM. No preoperative antibiotics are given Inhalational based with isoflurane Premedication with diazepam 0.1mg/kg, no preincision blocks, induction with fentanyl 2 mcg/kg, propofol 1 to 2 mg/kg till loss of response to verbal command,anesthesia maintenance with oxygen,nitrous oxide, isoflurane with Fio2 35% and MAC of 1, end operatively will receive ondansetron, intraoperative supplementation analgesia with IV fentanyl 0.5 mcg/kg if hemodynamics 20% of baseline. Fluids as per Holiday Segar formula. 20 ml of 0.25% Bupivacaine will be given as Wound infiltration at the time of skin closure. Post operative analgesics like injection paracetamol 1gm 8th hourly and injection tramadol 50mg iv SOS hourly will be given postoperatively . In morphine 1 mg/kg iv will be given at night. If VAS score 4 injection morphine will be given stat dose (not exceeding three dosed per day). Clear fluids to be started 6 hours postoperatively can can be converted to solid diet next day and maintenance iv fluids will be given up to 24 hour 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Female 
Details  All patients above 18 years of age attending surgery OPD with carcinoma breast planned for mastectomy with axillary dissection. 
 
ExclusionCriteria 
Details  Exclusion criteria
Past history of surgery on the same breast.
Prior history of radiation.
Patients requiring additional surgical procedures in the same setting.
ASA III & IV
 
 
Method of Generating Random Sequence   Stratified block randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
ERAS protocol when applied in breast surgery especially in MRM will result in early post-operative recovery, less use of opioid analgesics & decreased length of hospital stay.
 
Patient satisfaction on overall pain management during postoperative period using Likert scale at the time of discharge from hospital. Patient will be assessed for pain 6th hr,12th hr , and 24 hrs and then once daily for upto 72 hrs
 
 
Secondary Outcome  
Outcome  TimePoints 
A.Total amounts of postoperative opioids consumed in terms of total oral morphine equivalents (TME)
B. Patient satisfaction on overall pain management during postoperative period using Likert scale at the time of discharge from hospital.

 
Patient will be assessed for pain 6th hr,12th hr , & 24 hrs & then once daily for upto 72 hrs
 
 
Target Sample Size   Total Sample Size="76"
Sample Size from India="76" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   13/02/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Comparison of Enhanced Recovery After Surgery (ERAS) protocol with Conventional Care in patients undergoing Modified Radical Mastectomy for carcinoma breast- a Randomized Controlled Trial-[NIL]

In both groups, post-operative pain scores using VAS will be recorded at 6,12 and24 hrs and then once daily from 2nd postoperative day on-wards in both groups for up to 72 hours. Total amount of analgesics and opioids administered will be recorded and converted into Total oral morphine equivalents using www.clinicalc.com software. Presence of post-operative nausea and vomiting will be noted down. If vomiting present antiemetics will be given. Patients’ satisfaction using Likert’s 5 point scale with extremely satisfied to very dissatisfied, will be noted at the time of discharge. Length of Hospital stay will be recorded.

Length of the hospital stay will be calculated based on the discharge criteria  as mentioned below.

  1. Absence of early complications like surgical site infection, flap necrosis and infected drain fluid.

  2. Tolerating a normal diet.

  3. If drainage less than 50 ml for 2 consecutive days

  4. Adequate independent mobilization.

  5. Pain adequately controlled by oral analgesics(Vas score less than 4).

Readmission of patients in both groups and the reason for it will be documented.

  1. Data collection methods including settings and periodicity

 Preoperative data such as age, hemoglobin, albumin, prior chemotherapy, hormonal receptor status etc will be documented. 

Postoperatively pain recorded based on VAS score at 6, 12, 24 hrs and then once daily from 2nd postoperative day on-wards in both the groups upto 72 hours. Total amount of analgesics , both opioid and non-opioid analgesics consumed will be documented and converted into Total oral  morphine equivalents(TME) using clinical software.. Presence of post-operative nausea and vomiting will be noted down( 0- no nausea, 1- presence of nausea and 2 – vomiting present ). Patients’ satisfaction using Likert’s 5 point scale with extremely
 
Close